Colgate-Palmolive Company

Colgate-Palmolive Company

CLยทNYSE

$84.87

-4.0%
Consumer DefensiveHousehold & Personal Products

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$67.91B
EPS2.6400
P/E Ratio32.15
Earnings Date07/31/2026
3Y+13.0%
5Y+24.0%
10Y+34.0%
3Y+19.0%
5Y-21.0%
10Y-13.0%
3Y+64.0%
5Y+13.0%
10Y+34.0%
Colgate-Palmolive Company

Colgate-Palmolive Company Profit Bridge

CL ยท NYSE
Revenue20.38B
Cost of Goods Sold (8.13B)
Gross Profit12.25B
Operating Expenses (7.90B)
Operating Income4.35B
Interest Expense (267.00M)
Other Income/Expense-1.29B
Pretax Income3.06B
Income Tax (798.00M)
Net Income2.13B
Net Income
2.13B

Profitability Analysis

Gross Margin

60.1%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

21.3%

Healthy operating margins demonstrate effective cost control and strong business fundamentals.

Net Profit Margin

10.5%

Strong net margins indicate efficient operations and favorable tax/interest management.

Effective Tax Rate

26.1%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

Colgate-Palmolive Company Income Statement

CL โ€ข NYSE

Colgate-Palmolive Company Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
REVENUE
20.4B
20.1B
19.5B
18B
17.4B
16.5B
15.7B
15.5B
15.5B
15.2B
16B
17.3B
17.4B
17.1B
16.7B
15.6B
15.3B
15.3B
13.8B
12.2B
GROSS PROFIT
(8.1B)
(8B)
(8.2B)
(7.8B)
(7.1B)
(6.5B)
(6.4B)
(6.3B)
(6.1B)
(6.1B)
(6.7B)
(7.2B)
(7.2B)
(7.2B)
(7.1B)
(6.4B)
(6.3B)
(6.7B)
(5.9B)
(5.4B)
12.3B
12.1B
11.3B
10.2B
10.3B
9.9B
9.3B
9.2B
9.3B
9.1B
9.4B
10.1B
10.2B
9.9B
9.6B
9.2B
9B
8.7B
7.9B
6.9B
OPERATING INCOME
(7.9B)
(7.7B)
(7.1B)
(6.6B)
(6.4B)
(6B)
(5.5B)
(5.4B)
(5.3B)
(5.2B)
(5.4B)
(5.9B)
(6.1B)
(5.9B)
(5.7B)
(5.4B)
(5.3B)
(5.3B)
(4.9B)
(4.3B)
(7.9B)
(7.8B)
(6.8B)
(6.2B)
(6.1B)
(5.7B)
(5.2B)
(5.1B)
(5B)
(4.9B)
(5.1B)
(5.6B)
(5.8B)
(5.7B)
(5.5B)
(5.2B)
(5B)
(5.1B)
(4.7B)
(4.1B)
(0.0)
(355M)
(343M)
(320M)
(307M)
(290M)
(281M)
(277M)
(285M)
(289M)
(274M)
(277M)
(267M)
(259M)
(262M)
(256M)
(269M)
(253.1M)
(247M)
(241.5M)
4.3B
4.4B
4.1B
3.6B
3.9B
3.9B
3.8B
3.9B
4B
4B
4B
4.2B
4.1B
4B
3.9B
3.8B
3.7B
3.3B
2.9B
2.6B
PRE-TAX INCOME
(267M)
(292M)
(287M)
(167M)
(117M)
(160M)
(192M)
(193M)
(153M)
(149M)
(133M)
(130M)
(116M)
(80M)
(58M)
(65M)
(88M)
(105.6M)
(166.6M)
(166.6M)
-192M
-225M
-232M
-153M
-100M
-141M
-145M
-143M
-102M
-99M
-26M
-24M
9M
-15M
-52M
-59M
-77M
-95.6M
-156.6M
-158.7M
(0.0)
-442M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(6.2M)
(0.0)
-1.3B
-427M
-739M
-925M
-799M
-264M
-461M
-386M
-522M
-222M
-1.2B
-652M
-566M
-132M
-78M
-334M
-204M
-319.7M
-373.9M
-513.1M
3.1B
4B
3.4B
2.7B
3.1B
3.6B
3.3B
3.5B
3.5B
3.7B
2.8B
3.5B
3.6B
3.9B
3.8B
3.4B
3.5B
3B
2.6B
2.1B
NET INCOME
(798M)
(907M)
(937M)
(693M)
(749M)
(787M)
(774M)
(906M)
(1.3B)
(1.2B)
(1.2B)
(1.2B)
(1.2B)
(1.2B)
(1.2B)
(1.1B)
(1.1B)
(967.9M)
(759.1M)
(648.4M)
2.1B
2.9B
2.3B
1.8B
2.2B
2.7B
2.4B
2.4B
2B
2.4B
1.4B
2.2B
2.2B
2.5B
2.4B
2.2B
2.3B
2B
1.7B
1.4B

SEC Filings

CL - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 13, 2026
May 08, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 01, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 01, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 08, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 25, 2026
May 08, 2026
2026
8-K

8-K 2026

N/A

March 17, 2026
March 17, 2026
2026
8-K

8-K 2026

N/A

March 12, 2026
March 12, 2026
2026
10-K

10-K 2025 FY

FY

February 23, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 30, 2026
January 30, 2026
2026
8-K

8-K 2025

N/A

November 10, 2025
November 03, 2025
2025
Showing 1 to 10 of 393 filings